Delivery Order SPE2DB22D1103-SPE2DB24FTRB2

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $17,079.47 firm-fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a ceiling value of $17,079.47 and an ultimate completion date of September 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,462.78 firm fixed-price delivery order is for the supply of WEGOVY 1.7 mg/0.75 ml pens with a completion date of August 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various government agencies and healthcare programs. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The $1,097.08 firm fixed-price delivery order contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This contract is not associated with any set-aside programs. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal...
This federal contract award, valued at $1,956.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of July 22, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, supporting various defense and...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,663.62 firm-fixed-price delivery order is for the supply of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024 and does not utilize a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription medication. The award, valued at $2,261.41, is a firm-fixed-price delivery order with an ultimate completion date of August 30, 2024. This contract is not associated with any set-aside program. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts to supply a wide...
This federal contract award is a $1,286.44 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a prescription pharmaceutical product. The contract has an ultimate completion date of August 28, 2024 and is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $1,666.31 firm-fixed-price delivery order is for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5 ML, a pharmaceutical product. The contract has an ultimate completion date of August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $14,419.40, is a firm-fixed price delivery order for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,169.12 and a performance period ending on September 5, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its Corporate Office Division, has extensive experience in supplying a wide range...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRB2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $19,267.27 firm-fixed-price delivery order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 9, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation for delivering a comprehensive range of medical commodities. This award is not associated with a set-aside program.

Generated 12/6/24, 9:29 AM